View all active clinical trials around the US.
SparkCures Verified Accurate, up-to-date information. Learn more
Isatuximab, Carfilzomib, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multip...
ISATUXIMAB COMBINATION THERAPYIsatuximab Plus Lenalidomide and Dexamethasone for Frail and/or Much Older Patients With Newly Diagnosed Mu...
ISATUXIMAB IN FRAIL PATIENTSIsatuximab During Stem Cell Collection and Transplant in Patients With Multiple Myeloma and Lymphoma
ISATUXIMAB DURING STEM CELL TRANSPLANTPost-Transplant Maintenance Therapy With Isatuximab Plus Lenalidomide for High-Risk Multiple Myeloma Patients
POST-TRANSPLANT MAINTENANCE THERAPYStudy of Isatuximab Plus Pomalidomide and Dexamethasone in Highly Toxicity-vulnerable Subjects With Relapse...
ISATUXIMAB COMBINATION THERAPYA Phase 2 Study of Venetoclax in Combination With Isatuximab and Dexamethasone for Relapsed/Refractory Mult...
VENETOCLAX PLUS ISATUXIMAB AND DEXAMETHASONEThe following is a listing of clinical trials for patients with multiple myeloma who have been newly diagnosed or have not yet received treatment.
The following is a listing of clinical trials for patients with multiple myeloma who have received one to two prior lines of therapy.
SparkCures Verified Accurate, up-to-date information. Learn more
Isatuximab, Carfilzomib, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multip...
ISATUXIMAB COMBINATION THERAPYIsatuximab During Stem Cell Collection and Transplant in Patients With Multiple Myeloma and Lymphoma
ISATUXIMAB DURING STEM CELL TRANSPLANTStudy of Isatuximab Plus Pomalidomide and Dexamethasone in Highly Toxicity-vulnerable Subjects With Relapse...
ISATUXIMAB COMBINATION THERAPYThe following is a listing of clinical trials for patients with multiple myeloma who have received three or more prior lines of therapy.
SparkCures Verified Accurate, up-to-date information. Learn more
Isatuximab, Carfilzomib, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multip...
ISATUXIMAB COMBINATION THERAPYStudy of Isatuximab Plus Pomalidomide and Dexamethasone in Highly Toxicity-vulnerable Subjects With Relapse...
ISATUXIMAB COMBINATION THERAPYThe following is a listing of clinical trials for patients with Monoclonal Gammopathy of Undetermined Significance (MGUS).